Megan J Kirkley1,2, Louis Boohaker3, Russell Griffin4, Danielle E Soranno5, Jason Gien6, David Askenazi7, Katja M Gist8. 1. Section of Neonatology, Department of Pediatrics, University of Colorado, Aurora, CO, USA. Megan.Kirkley@childrenscolorado.org. 2. University of Colorado, Anschutz Medical Campus 13123 E 16th Avenue, B158, Aurora, CO, 80045, USA. Megan.Kirkley@childrenscolorado.org. 3. Pediatric and Infant Center for Acute Nephrology, University of Alabama, Birmingham, AL, USA. 4. Department of Epidemiology, University of Alabama, Birmingham, AL, USA. 5. Section of Nephrology, Department of Pediatrics, University of Colorado, Aurora, CO, USA. 6. Section of Neonatology, Department of Pediatrics, University of Colorado, Aurora, CO, USA. 7. Pediatric and Infant Center for Acute Nephrology, Department of Pediatrics, University of Alabama, Birmingham, AL, USA. 8. Section of Pediatric Cardiology, Department of Pediatrics, University of Colorado, Aurora, CO, USA.
Abstract
BACKGROUND: Acute kidney injury (AKI) is common in neonatal encephalopathy (NE) and is associated with worse outcomes. Our objectives were to determine the incidence, risk factors, and outcomes of AKI in infants with NE. METHODS: We performed a retrospective analysis of infants ≥ 34 weeks' gestational age with a diagnosis of NE from the Analysis of Worldwide Acute Kidney injury Epidemiology in Neonates (AWAKEN) database. AKI was defined using the modified Kidney Disease Improving Global Outcomes criteria. Perinatal and postnatal factors were evaluated. Multivariate logistic and linear regressions were performed. RESULTS: One hundred and thirteen patients with NE were included. 41.6% (47) developed AKI. Being born outside the admitting institution (OR 4.3; 95% CI 1.2-14.8; p = 0.02), intrauterine growth restriction (OR 10.3, 95% CI 1.1-100.5; p = 0.04), and meconium at delivery (OR 2.8, 95% CI 1.04-7.7; p = 0.04) conferred increased odds of AKI. After controlling for confounders, infants with AKI stayed in the hospital an average of 8.5 days longer than infants without AKI (95% CI 0.79-16.2 days; p = 0.03). CONCLUSIONS: In this multi-national analysis, several important perinatal factors were associated with AKI and infants with both NE and AKI had longer length of stay than NE alone. Future research aimed at early AKI detection, renoprotective management strategies, and understanding the long-term renal consequences is warranted in this high-risk group of patients.
BACKGROUND:Acute kidney injury (AKI) is common in neonatal encephalopathy (NE) and is associated with worse outcomes. Our objectives were to determine the incidence, risk factors, and outcomes of AKI in infants with NE. METHODS: We performed a retrospective analysis of infants ≥ 34 weeks' gestational age with a diagnosis of NE from the Analysis of Worldwide Acute Kidney injury Epidemiology in Neonates (AWAKEN) database. AKI was defined using the modified Kidney Disease Improving Global Outcomes criteria. Perinatal and postnatal factors were evaluated. Multivariate logistic and linear regressions were performed. RESULTS: One hundred and thirteen patients with NE were included. 41.6% (47) developed AKI. Being born outside the admitting institution (OR 4.3; 95% CI 1.2-14.8; p = 0.02), intrauterine growth restriction (OR 10.3, 95% CI 1.1-100.5; p = 0.04), and meconium at delivery (OR 2.8, 95% CI 1.04-7.7; p = 0.04) conferred increased odds of AKI. After controlling for confounders, infants with AKI stayed in the hospital an average of 8.5 days longer than infants without AKI (95% CI 0.79-16.2 days; p = 0.03). CONCLUSIONS: In this multi-national analysis, several important perinatal factors were associated with AKI and infants with both NE and AKI had longer length of stay than NE alone. Future research aimed at early AKI detection, renoprotective management strategies, and understanding the long-term renal consequences is warranted in this high-risk group of patients.
Authors: Joseph T Flynn; David C Kaelber; Carissa M Baker-Smith; Douglas Blowey; Aaron E Carroll; Stephen R Daniels; Sarah D de Ferranti; Janis M Dionne; Bonita Falkner; Susan K Flinn; Samuel S Gidding; Celeste Goodwin; Michael G Leu; Makia E Powers; Corinna Rea; Joshua Samuels; Madeline Simasek; Vidhu V Thaker; Elaine M Urbina Journal: Pediatrics Date: 2017-08-21 Impact factor: 7.124
Authors: David T Selewski; Jennifer R Charlton; Jennifer G Jetton; Ronnie Guillet; Maroun J Mhanna; David J Askenazi; Alison L Kent Journal: Pediatrics Date: 2015-07-13 Impact factor: 7.124
Authors: Matthew W Harer; David T Selewski; Kianoush Kashani; Rajit K Basu; Katja M Gist; Jennifer G Jetton; Scott M Sutherland; Michael Zappitelli; Stuart L Goldstein; Theresa Ann Mottes; David J Askenazi Journal: J Perinatol Date: 2020-09-05 Impact factor: 2.521
Authors: Mountasser M Al-Mouqdad; Dima Z Jamjoom; Ayman T Abdalgader; Waleed S Ameen; Thanaa M Khalil; Yasmeen S Asfour; Maha R Al-Anazi; Suzan S Asfour Journal: Pediatr Nephrol Date: 2022-03-31 Impact factor: 3.651
Authors: Leonardo Trasande; Sandra India Aldana; Howard Trachtman; Kurunthachalam Kannan; Deborah Morrison; Dimitri A Christakis; Kathryn Whitlock; Mary Jo Messito; Rachel S Gross; Rajendiran Karthikraj; Sheela Sathyanarayana Journal: Environ Pollut Date: 2019-10-23 Impact factor: 8.071
Authors: Neel Deferm; Kim V Annink; Ruben Faelens; Michael Schroth; Christian A Maiwald; Loubna El Bakkali; Frank van Bel; Manon J N L Benders; Mirjam M van Weissenbruch; Anja Hagen; Anne Smits; Pieter Annaert; Axel R Franz; Karel Allegaert Journal: Clin Pharmacokinet Date: 2021-02-21 Impact factor: 6.447
Authors: Adam Frymoyer; Krisa P Van Meurs; David R Drover; Jelena Klawitter; Uwe Christians; Valerie Y Chock Journal: Pediatr Res Date: 2020-09-12 Impact factor: 3.756